Please login to the form below

Not currently logged in
Email:
Password:

licensing

This page shows the latest licensing news and features for those working in and with pharma, biotech and healthcare.

Celgene files luspatercept ahead of key merger vote

Celgene files luspatercept ahead of key merger vote

Luspatercept’s eventual approval will be a rare case of highly value-creating in-licensing from Celgene: the firm signed the deal with Acceleron in 2011 for $25m upfront and up

Latest news

More from news
Approximately 7 fully matching, plus 564 partially matching documents found.

Latest Intelligence

  • The Orkambi row explained The Orkambi row explained

    It has called for a Crown Use compulsory licensing of Orkambi, but this always looked like an outside bet. ... It urges the government to use Crown use compulsory licensing to gain access to cheaper versions of Orkambi.

  • #OrkambiNow? #OrkambiNow?

    UK government to issue a compulsory licensing of Orkambi. ... For example in Germany, from the time of European licensing, adults and children of 12 and over were able to access Orkambi if they had the right mutations.”.

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    Successful projects may then be considered for licensing to industrial partners to facilitate the progression of novel treatments into the clinic.

  • The UK’s new five-year pricing agreement The UK’s new five-year pricing agreement

    Scheme operation. Continued support for innovative medicines in the first three years post-licensing, including freedom of list pricing for new active substances and immediate line extensions.

  • Deal Watch October 2018

    Licensing &. research. collaboration. $550m. Novartis/. Mylan. TOBI Podhaler and TOBI solution for cystic fibrosis. ... So two opportunities here – acquisition of animal health products and out-licensing to Bayer’s pharma business.

More from intelligence
Approximately 5 fully matching, plus 87 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 43 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics